Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-28 @ 9:59 AM
Study NCT ID:
NCT03166761
Status:
TERMINATED
Last Update Posted:
2024-07-10
First Post:
2017-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection
Sponsor:
Vanderbilt University Medical Center
Organization:
Study Overview
Official Title:
Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection
Status:
TERMINATED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
recruitment and staffing
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections
Detailed Description:
Patients eligible for a sacroiliac joint injection will be randomized to receive one of two different steroids, dexamethasone or triamcinolone. The response immediately after injection will be assessed to confirm the diagnosis, and then they will be followed for three month to assess the degree of pain relief experienced
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: